New heart plug could free AF patients from lifelong blood thinners

NCT ID NCT03616028

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the Conformal Left Atrial Appendage Seal in 64 adults with non-valvular atrial fibrillation who are at high risk for stroke. The device is placed to close off a small pouch in the heart where blood clots can form, offering an alternative to long-term blood thinner medication. The main goals are to check safety and how well the device seals the pouch.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-VALVULAR ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Scott & white Research Institute

    Plano, Texas, 75093, United States

  • Catholic Medical Center

    Manchester, New Hampshire, 03102, United States

  • Columbia University Medical Center/NYPH

    New York, New York, 10032, United States

  • Erlanger Health System

    Chattanooga, Tennessee, 37403, United States

  • Lankenau Heart Institute

    Wynnewood, Pennsylvania, 19096, United States

  • Mount Sinai

    New York, New York, 10029, United States

  • Pacific Heart Institute

    Santa Monica, California, 90404, United States

  • St. Bernards Medical Center

    Jonesboro, Arkansas, 72401, United States

  • Texas Cardiac Arrhythmia Institute

    Austin, Texas, 78705, United States

  • The Christ Hospital

    Cincinnati, Ohio, 45219, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.